VerImmune Inc
Tuesday, February 27, 2024
Uris
Platform for Therapeutics
VerImmune Inc is developing a highly innovative Virus-inspired Particle (ViP™) platform technology that has the potential to treat multiple diseases, with an initial focus on Oncology.
State
DC
Country
United States
Website
http://www.verimmune.com
CEO/Top Company Official
Joshua Wang
Lead Product in Development
VERI-101
Development Phase of Primary Product
Pre-Clinical
Number Of Unlicensed Products
Multiple opportunities for co-discovery